cv dr eslam final - pasteurfa.pasteur.ac.ir/userfiles/file/amozesh/cv asatid 92/cv dr...curriculum...

1

Curriculum Vitae

Name: Ali Eslamifar

Address: Electron Microscopy and Clinical Research Department, Pasteur Institute of

Iran (IPI), No. 69, Pasteur Ave., Tehran 1316943551, Iran

Tel: (+98-21) 66968852

Fax: (+98-21) 66465147

E-mail: [email protected]

Education:

• 2001 Electron microscopy, Shaheed Beheshti University of Medical

Sciences and Health Services, Tehran, Iran.

• 1997-2001 Pathology Specialty (Anatomical & Clinical): Shaheed

Beheshti University of Medical Sciences and Health Services, Tehran,

Iran.

• 1989-1996 MD. Shaheed Beheshti University of Medical Sciences and

Health Services, Tehran, Iran.

Teaching Course:

• Electron microscopy course for M.Sc. & PhD students of Tehran medical

university

• Electron microscopy course for M.Sc. & PhD students of Institute Pasteur

of Iran

2

• Electron microscopy course for M.Sc. & PhD. students of Shahreh Kord

Medical University Electron microscopy course for M.Sc. & PhD students

of Pasteur Institute of Iran

• Electron microscopy course for M.Sc. & PhD. students of Tarbiat

Modarres University

• Pathology course for M.Sc. & PhD students of Pasteur Institute of Iran

• Cellular biology for Biotechnology PhD students of Tehran medical

university

Membership:

• Member of Iranian Society of Pathology

• Member of Iranian Cancer Society

• Member of Board in Iranian Physician Council

• Member of Scientific Executive Committee of Iranian Infectious Diseases

Conferences (12th-21st)

• Member of Specialized Committee on Research Projects

• Member of Regional Committee on Ethics

• Reviewer of Iranian journal of infectious disease and tropical medicine

• Member of Scientific Committee of National Congress on

Brucellosis(2011)

Positions:

• Director and Head of Special Services of Pasteur Institute of Iran

• Director and Head of Clinical Research Dept., Pasteur Institute of Iran

3

• Director and Head of Electron Microscopy Dept., Pasteur Institute of Iran

Recent Projects:

• Comparing efficacy of two strategies of HBV vaccination in HIV infected

patients (2012-2015)

• Frequency of human papillomavirus infection in colon tissues of patients

with colon adenocarcinoma and adenomatous polyps referring to Shaheed

Beheshti University hospitals (2012)

• Frequency of occult Hepatitis B infection and S gene mutations in dialysis

patients (2012)

• Seroepidemiology of IgG antibodies against Diphtheria and Tetanus in

blood donors of Arak city(2012)

• Serum profile of T helper 1 and 2 cytokines in patients with chronic

hepatitis C virus infection(2011)

• Association of interleukin-10 gene promoter polymorphisms with outcome

of hepatitis B virus infection (2011)

• TH1/TH2 cytokine levels as an indicator for disease progression in human

immunodeficiency virus type 1 infected patients(2011)

• Seroepidemiology of IgG antibody against Bordetella pertussis in 6-20

years age group habitant of Tehran (2009-2010)


years age group habitant of Tehran(2009-2010)

• Occult hepatitis B virus infection and mutations in the S gene region in

vaccinated children(2009-2010)

4

• Frequency of human papillomavirus infection in patients with breast

carcinoma and benign breast samples referring to Shohada , Loghman and

Imam Khomeini hospitals (2009-2010)

• Association of polymorphism of HLA-DRB1*13 and HLA-A*33 alleles

with outcome of hepatitis B virus infection (2008-2010)

• Frequency of human papillomavirus infection in patients with breast

carcinoma and benign breast samples referring to Shohada , Loghman and

Imam Khomeini hospitals (2009-2010)


years age group habitant of Tehran(2009-2010)

• Frequency of occult Hepatitis B virus infection in blood donors with

isolated anti-HBc in Arak city (2009)

• Frequency of human papillomavirus infection in prostate tissues of

patients with prostate carcinoma and benign prostatic hyperplasia referring

to Shaheed Beheshti University hospitals (2008-2010)

• The effect of chronic L-arginine administration on endothelial cell

apoptosis and serum antioxidant level in high-cholesterol fed rabbits

(2007)

• Hepatitis B virus genotyping in hepatocellular carcinoma in Iranian

patients (2006-2007)

• Trial due to recombinant hepatitis B (HB) vaccine in hemodialysis patients

of 3 dialysis center of Imam Khomeini, Sina, Amiralam Hospitals (2005-

2007)

• Frequency of Hepatitis G (HGV) in Hemodialysis and peritoneal dialysis

patients and dialysis ward staff in Imam Khomeini Hospital (2005-2006)

5

• Frequency of Hepatitis G (HGV) in Blood Donors in Tabriz (2005-2006)

• Association between HPV and cervical cancer in Yazd province of Iran

(2005-2006)

• Identification, genetic characterization, drug susceptibility patterns and

clinical outcome of enterococcal strains isolated from patients in Tehran

(2001-2005)

• The role of fungi and HLA antigens in the etiology of chronic rhino

sinusitis in individuals admitted to the Shahid Beheshti Medical Sciences

Hospitals (2004-2006)

• Study of prevalence of HPV16 and HPV18 in patients with esophageal

carcinoma in Iran (2003-2005)

Publications (International):

• Ramezani A, …….., Eslamifar A , Mohraz M, Banifazl M, Bidari-Zerehpoosh

F, Yaghmaei F, McFarland W, …….., Mostafavi E and Aghakhani A.

Hepatitis E Virus Infection in Patients Infected with HIV in an Endemic Area

in Iran.International Journal of STD & AIDS (in press)

• Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M, ….,

Eslamifar A, Sadat M, Ramezani A . Frequency and Genotype of Hepatitis D

Virus Infection in Patients Infected with HIV and Hemodialysis Patients.

Hepatitis Monthly (in press)

• Sofian M, Kalantar E, Aghakhani A, Hosseini S, Banifazl M, ….., Eslamifar A

and Ramezani A. No Correlation between Interleukin-10 Gene Promoter

Polymorphisms and Hepatitis B Virus Infection Outcome. Hepatitis Monthly

(in press)

6

• Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi SH,

Aghakhani A, Mashayekhi P. Seroprevalence of Hepatitis E Virus infection

among Volunteer Blood Donors in Central Province of Iran in 2012. Iranian

Journal of Microbiology (in press)

• Ramezani A, Banifazl M, Eslamifar A , Ahmadi F, Razeghi E and Aghakhani

A. Outcome of Hemodialysis Patients with Occult Hepatitis B Virus Infection

At 4 Year Follow-up. Journal of Gastrointestinal and Liver Diseases 22(1):12-

15(2013)

• Sofian M, Sheikholeslami M, Mahdaviani F, Aghakhani A, Banifaz M,

Eslamifar A, Sarmadian H, Deiri G, Ramezani A. Low Prevalence of Brucella

agglutinins in Blood Donors in Central Province of Iran. Iranian Journal of

Microbiology 5(1):24-27(2013)

• Sofian M, Aghakhani A, FaraziA, Banifazl M, Eslamifar A, Rashidi N,

Khadem-Sadegh A and Ramezani A. Serum Profile of T helper 1 and T helper

2 Cytokines in Hepatitis C virus Infected Patients. Hepatitis Monthly

12(12):e6156 (2012)

• Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi A, McFarland W,

Eslamifar A and Ramezani A. Viral hepatitis and HIV infection among

injection drug users in a central Iranian city. Journal of Addiction Medicine

6(4):292-6 (2012)

• Aghakhani A, Banifazl M, Eslamifar A, Ahmadi F and Ramezani A. Viral

Hepatitis and HIV Infection in Hemodialysis Patients. Hepatitis Monthly

12(7): 463-464(2012)

7

• Ramezani A, Banifazl M, Eslamifar A, Sofian M and Aghakhani A. Occult

hepatitis B infection in different high risk patients. Hepatitis Monthly 12(7):

467-468(2012)

• Aghakhani A, Banifazl M, Velayati AA, Eslamifar A and Ramezani A. Occult

Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for

Consideration. Therapeutic Apheresis and Dialysis 16(4):328-33(2012)

• Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A and Aghakhani

A. The Influence of Human Leukocyte Antigen and IL-10 Gene

Polymorphisms in Hepatitis B Virus Outcome. Hepatitis Monthly 12(5):320-

325(2012)

• Eslamifar A, Ramezani A, Banifazl M, Khadem-Sadegh A and Aghakhani A.

Seroprevalence of IgG Antibodies against Bordetella Pertussis in Different

Age Groups in Tehran. Iranian Journal of Pathology 7(3):171-176(2012)

• Soufian S , Aghakhani A, Mohraz M, Banifazl M, Eslamifar A, Boland-

Ghamat Z, Khadem-Sadegh A and Ramezani A. No evidence of the Th1 to

Th2 cytokine shift during the course of HIV infection. Iranian Journal of

Pathology 7(2):88-93(2012)

• Eslamifar A,

Ramezani A, Banifazl M and Aghakhani A. Tetanus and

diphtheria seroprevalence in patients infected with human immunodeficiency

virus. Iranian Journal of Pathology 7(1):27-31(2012)

• Ramezani A, Banifazl M, Mohraz M, Eslamifar A, Rasoolinejad M and

Aghakhani A. Occult Hepatitis B Virus Infection: A Major Concern in HIV-

Infected Patients. Hepatitis Monthly 11(1):7-10 (2011)

• Aghakhani A, Banifazl M, Izadi N, McFarland W, Sofian M, Khadem-Sadegh

A,….Eslamifar A, Ramezani A. Persistence of antibody to hepatitis B surface

8

antigen among vaccinated children in a low HBV endemic area. World Journal

of Pediatrics 7(4):358-60 (2011)

• Aghakhani A, Hamkar R, Parvin M, …., Banifazl M, Eslamifar A, Izadi N,

Jam S and Ramezani A. The Role of Human Papillomavirus Infection in

Prostate Carcinoma. Scandinavian Journal of Infectious Diseases 43(1): 64-

69(2011)

• Ramezani A, Banifazl M, Eslamifar A and Aghakhani A. Association between

Human Papillomavirus Infection and Risk of Prostate Cancer (Review article).

Iranian Journal of Pathology 6 (1): 3-7(2011)

• Hamkar R, Mohraz M, Lorestani S, Aghakhani A, Truong HM, McFarland W,

Banifazl M, Eslamifar A, ……. and Ramezani A. Assessing Subtype and

Drug-Resistance Associated Mutations among Antiretroviral-Treated HIV

Infected Patients. AIDS 24 (suppl 2):S85–S91 (2010)

• Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Khadem-Sadegh A and

Ramezani A. Occult Hepatitis B Virus Infection in Hemodialysis Patients with

Isolated Hepatitis B Core Antibody: A Multicentre Study. Therapeutic

Apheresis and Dialysis 14(3):349–353 (2010)

• Ramezani A, Banifazl M, EslamifarA and Aghakhani A. Serological pattern of

anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals

in Iran. Journal of Infection in Developing Countries 4(10):658-661 (2010)

• Sofian M, Aghakhani A, Farazi AA, Banifazl M, …, Eslamifar A, Khadem-

Sadegh A, Izadi N and Ramezani A. Seroepidemiology of Hepatitis A Virus in

Children of Different Age Groups in Tehran, Iran: Implications for Health

Policy. Travel Medicine and Infectious Disease 8(3): 176-179 (2010)

9

• Sofian M, Aghakhani A, Banifazl M, …Eslamifar A,…Ramezani A. Lack

of occult hepatitis B virus infection among blood donors with isolated anti-

HBc living in a HBV low prevalence region in Iran. International Journal

of Infectious Diseases 14(4):e308–e310 (2010)

• Hamkar R, Aghakhani A, Soufian S, Banifazl M, ….., Eslamifar A and

Ramezani A. Surface Gene Mutations of Hepatitis B Virus among High

Risk Patients with Occult HBV Infection. Diagnostic Microbiology and

Infectious Disease 66(3):285-291(2010)

• Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M,

….Ramezani A. Hepatitis B Virus Genotype in Iranian Patients with

Hepatocellular Carcinoma . International Journal of Infectious Diseas13

(6):685-89(2009).

• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A,

Khadem-Sadegh A, Velayati AA. Frequency of Isolated Hepatitis B Core

Antibody in HIV-HCV Coinfected Individuals. International Journal of

STD & AIDS 20(5):336-338(2009)

• Ramezani A, Aghakhani A, Kalantar E, Eslamifar A, Banifazl M and

Velayati AA. HLA-A*3303 and *3301 Predispose Patients to Persistent

Hepatitis B Infection. Journal of Gastrointestinal and Liver Diseases

18(1):117-8(2009)

• Kariminia A, sharifnia Z, Aghakhani A, Banifazl M, Eslamifar A, Hazrati

M and Ramezani A. Comparison of QuantiFERON TB-G test to TST for

detecting latent tuberculosis infection in a high-incidence area containing

BCG-vaccinated population. Journal of Evaluation in Clinical

Practice15:148–151(2009)

10

• Ramezani A, Eslamifar A, ……and Aghakhani A. Efficacy and Long-term

Immunogenicity of Hepatitis B Vaccine in Hemodialysis Patients.

International Journal of Clinical Practice 63(3): 394-97(2009)

• Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A,….Taeb J,

Aghakhani A… Association of Human Leukocyte Antigen polymorphism

with Outcomes to Hepatitis B Virus Infection. Journal of Gastroenterology

and Hepatology 23(11):1716-1721 (2008).

• Ramezani A, Mohraz M, Vahabpour R,….Eslamifar A,….Aghakhani

A,…Hekmat S. Frequency of Hepatitis G Virus Infection among HIV

Positive Subjects with Parenteral and Sexual Exposure. Journal of

Gastrointestinal and Liver Diseases 17(3):269-72 (2008)

• Azadmanesh K, Mohraz M, Aghakhani A,……..Eslamifar A,….Ramezani

A. Occult Hepatitis B Virus Infection in HIV-Infected Patients with

Isolated Hepatitis B Core Antibody. Intervirology 51(4):270-274 (2008)

• Hekmat S, Mohraz M, Vahabpour R, Jam S, Bahramali G, Banifazl M,

Aghakhani A, Eslamifar A, Mahboudi F, Edalat R, Ramezani A.

Frequency and Genotype of GB Virus C among Iranian Patients Infected

with HIV. Journal of Medical Virology 80(11):1941-1946(2008)

• Ramezani A, Mohraz M, Banifazl M,….Eslamifar A,….and Aghakhani A.

Frequency and Associated Factors of Proteinuria in Iranian HIV-Positive

Patients. International Journal of Infectious Diseases 12(5):490-494(2008)

• Ramezani A, Eslamifar A,, ……and Aghakhani A. Persistence of Hepatitis

B Vaccine Immunity in Hemodialysis Patients .Therapeutic Apheresis and

Dialysis.12(2):143-146 (2008).

11

• Sofian M., Aghakhani A., Velayati A.A., Banifazl M, Eslamifar A. and

Ramezani A. Risk factors for human brucellosis in Iran: a case control

study. International Journal of Infectious Diseases 12(2):157-61(2008)

• Ramezani A. Gachkar L, Eslamifar A,….Detection of hepatitis G virus

envelope protein E2 antibody in blood donors. International Journal of

Infectious Diseases. 12(1):57-61(2008)

• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G

virus (HGV) Exposure in Dialysis Staff. Therapeutic Apheresis and

Dialysis. 11(5):370-374(2007)

• Norouzian D, Akbarzadeh A, …..and Eslamifar A. Stabilization of

Tyrosinase-Bovine serum albumin crystals by Glutaraldehyde. American

journal of Biochemistry and Biotechnology. 3(3):110-113(2007).

• Eslamifar Ali, Aghakhani A, Hamkar R, Ramezani A, et al..... Frequency

of Human Papillomavirus Infection in Iranian Esophageal Squamous Cell

Carcinoma patients. Scandinavian Journal of Infectious Disease .39(1):58-

62(2007)

• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G

Virus Exposure in Dialysis Patients. International Urology and

Nephrology .39(4): 1257-1263 (2007).

• Razzaghi-abyaneh M, Shams-Ghahfarokhi M, Eslamifar A. Inhibitory

effects of Akacid on growth and aflatoxin production by Aspergillus

parasiticus. Mycopathologia, Vol. 161: 245-249. (2006)

• Razzaghi-Abyaneh M, Shams-Ghahfarokhi M, Eslamifar A.

Ultrastructural evidences of growth inhibitory effects of a novel biocide,

Akasid. Toxicon, 48: 1075-1082. (2006)

12

• Sayah M, Beheshti S, Shokrgozar M.A, Eslamifar A, Deljoo Z. Anti

epileptogenic and anticonvulsant activity of interleukin 1β in amygdala-

kindled rats experimental neurology(2004)

Journal papers (Persian)

• Eslamifar A, Aghakhani A, Mohraz M, Banifazl M, Foroughi M, Ansari F,

Bolandghamat Z, Ramezani A. Seroepidemiology of Hepatitis E Virus

Infection in HIV Infected Patients. Iranian Journal of Infectious Diseases

and Tropical Medicine 17(59):33-36(2013)

• Soufian S, Mohraz M, Aghakhani A, Banifazl M, Froughi M, Eslamifar A,

Boland-Ghamat Z, Khadem-Sadegh A and Ramezani A. TH1/TH2

Cytokine Levels in Human Immunodeficiency Virus Type 1 Infected

Patient. Iranian Journal of Infectious Diseases and Tropical Medicine

16(55):19-22(2012)

• Kalantar E, Ramezani A, Hosseini S, Aghakhani A, Zarin Far N, Banifazl

M ,………Eslamifar A and Sofian M. Interleukin-10 gene promoter

polymorphisms and hepatitis B virus infection outcome. Iranian Journal of

Infectious Diseases and Tropical Medicine 16(54):7-12(2011)

• Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl

M…… Eslamifar A and Ramezani A. Frequency of hepatitis D virus

infection in HIV positive and hemodialysis patients. Iranian Journal of


• Ramezani A, Hamkar R, Aghakhani A, Lorestani SH, Banifazl M, Truong

HH, McFarland W, Foroughi M, Eslamifar A and Mohraz M. Subtype

Mutations and Related Drug-Resistance in Anti-Retroviral Treated HIV

13

Infected Patients. Iranian Journal of Infectious Diseases and Tropical

Medicine15(50):1-7(2010)

• Izadi N, Aghakhani A, Banifazl M , … Eslamifar A , .., Khadem-Sadegh A

and Ramezani A. Persistence of Anti-HBs antibody in HB Vaccinated

Children in a Low Endemic Area for HBV. Iranian Journal of Infectious

Diseases and Tropical Medicine 14(47):39-42(2010)

• Eslamifar A, Aghakhani A, Banifazl M, Gachkar L, Khadem-Sadegh A,

Ramezani A. Seroprevalence of Bordetella Pertussis Antibodies in

Different Age Groups. Iranian Journal of Infectious Diseases and Tropical

Medicine 15(49):43-47(2010)

• Hamkar R, Parvin M, Ghavami N, Ramezani A, …, Banifazl M, ….,

Eslamifar A and Aghakhani A. Involvement of Human Papillomavirus

Infection in Prostate Carcinoma. Iranian Journal of Infectious Diseases and

Tropical Medicine 15(48):13-17(2010)

• Ramezani A, Azadmanesh K, Aghakhani A, Banifazl M, …. and Sofian

M. Frequency of occult hepatitis B virus infection in injection drug users.

Iranian Journal of Infectious Diseases and Tropical Medicine 15(48):39-

42(2010)

• Ramezani A, Hamkar R, Soufian S, Banifazl M ,……, Eslamifar A and

Aghakhani A. Genetic variability of the S gene of hepatitis B virus among

High Risk Patients with Occult HBV Infection. Iranian Journal of


• Velayati AA, Aghakhani A,....Eslamifar A....Ramezani A. Association of

polymorphism of HLA-DRB1*13 and HLA-A*33 alleles with outcome of

14

hepatitis B virus infection. Iranian Journal of Infectious Diseases and

Tropical Medicine 14(46): 11-14 (2009)

• Ramezani A, Sofian M, Banifazl M, …., Eslamifar A, Gachkar L,

Khadem-Sadegh A and Aghakhani A. Seroepidemiology of Hepatitis A

Virus in Children Residing in Tehran. Iranian Journal of Infectious

Diseases and Tropical Medicine 14(46):23-26 (2009)

• Ramezani A, Banifazl M, Eslamifar A, Gachkar L, Aghakhani A.

Prevalence of hepatitis G virus in the sera of HIV infected patients with

parenteral and sexual exposure. Iranian Journal of Infectious Diseases and

Tropical Medicine 14(45):27-29(2009)

• Ramezani A, Aghakhani A,…….. Eslamifar A, Sofian M. Occult hepatitis

B virus infection among blood donors in Arak. Iranian Journal of


• Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, Mohraz M.

Frequency of isolated anti-HBc in HIV- HCV co-infected patients. Iranian

Journal of Infectious Diseases and Tropical Medicine 14(45):17-22(2009)

• Ramezani A, Banifazl M,……Eslamifar A…..and Aghakhani A. Occult

hepatitis B virus infection in hemodialysis patients. Iranian Journal of

Infectious Diseases and Tropical Medicine14(44):27-30

• Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani A.

Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis

B Virus Infection. Iranian Journal of Pathology 4(2):80-84(2009)

• Ramezani A, Aghakhani A, Kalantar E, Banifazl M, Eslamifar A ,Velayati

AA. Association between Hepatitis B Virus Infection Outcome and HLA-

15

A and DRB1 Genotyping in North Part of Iran. Iranian Journal of

Pathology 4(2):71-74(2009)

• Ramezani A, Mohraz M,….,Aghakhani A, Eslamifar A…..Prevalence of

dyslipidemia and metabolic abnormalities in HIV-infected patients. Acta

Medica Iranica 47(2):83-88(2009)

• Ramezani A, ………Aghakhani A, Eslamifar A,…and Mohraz M.

Frequency of Occult Hepatitis B Virus Infection in HIV Infected Patients.

Iranian Journal of Infectious Diseases and Tropical Medicine13(43):17-

20(2009)

• Aghakhani A, Mohraz M, Banifazl M, …. Eslamifar A,…and Ramezani

A. Asymptomatic proteinuria in HIV-infected outpatients. Iranian Journal

of Infectious Diseases and Tropical Medicine 13(42):9-13(2008)

• Ramezani A, Eslamifar A,…… Aghakhani A ,…. High Blood Mercury

Levels in Iranian Infants: cause for concern. Iranian Journal of Pathology

3(4):186-190 (2008)

• Zahmatkesh M, Khadkhodaie M, …..Eslamifar A, Taeb J,…Proteinuria is

reduced by inhibition of inducible nitric oxide synthase in rat renal

ischemia/perfusion injury. Urmia Medical Journal.19(2):34-41(2008)

• Eslamifar A, Razzaghi-Abyaneh M,…… Ramezani A, Deljoodokht Z and

Aghakhani A. Frequency and Identification of Fungal Strains in Chronic

Rhinosinusitis Patients. Iranian Journal of Pathology 3(3):135-139(2008)

• Ramezani A, Aghakhani A ,… Eslamifar A,….Anemia prevalence and

related factors in a cohort of HIV- infected patients .Iranian Journal of

Pathology 3(3):125-128(2008)

16

• Hamkar R, Zamani N, Ramezani A, Eslamifar A, ......and Aghakhani A.

Identification of Hepatitis B Virus Genotype in Iranian Hepatocellular

Carcinoma Patients. Iranian Journal of Infectious Diseases and Tropical

Medicine13(41):23-29(2008)

• Ramezani A,…… Aghakhani A, Eslamifar A,….. Prevalence and

Genotype of Hepatitis G virus infection in HIV Positive Patients. Iranian

Journal of Infectious Diseases and Tropical Medicine13(41):7-13(2008)

• Ramezani A, Aghakhani A, Eslamifar A….Taeb J,….. Long-Term

Immunity of Hepatitis B Vaccine in Patients Undergoing Hemodialysis.

Iranian Journal of Infectious Diseases and Tropical Medicine.13(40):21-

24(2008)

• Kariminia A, sharifnia Z, Aghakhani A, .. Eslamifar A,… and Ramezani

A. Evaluation of the blood gamma interferon assay for detection of latent

Tuberculosis infection: potential to replace the Mantoux skin test. Iranian

Journal of Infectious Diseases and Tropical Medicine13 (40):1-4(2008).

• Eslamifar A, Ramezani A, Razzaghi Abyaneh M, Fallahian V,

Mashayekhi P, Hazrati M, Askari T, Fayaz A and Aghakhani A. Animal

Bites in Tehran, Iran. Archives of Iranian Medicine 11(2):200-202(2008)

• Ramezani A, Mohraz M, Banifazl M,….Eslamifar A,….and Aghakhani A.

Metabolic abnormalities in HIV-positive patients receiving highly active

antiretroviral therapy. Iranian Journal of Pathology2 (4):154-58 (2007).

• Jam S, Sabzevari D, Aghakhani A, Eslamifar A, Banifazl M and Ramezani

A. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas

17

aeruginosa in a pediatric hospital. Iranian Journal of Pathology 2(4):144-

48(2007)

• Soofian M,…. Eslamifar A, Aghakhani A, Ramezani A. Eosinophilic

gastroenteritis: A case report. Iranian Journal of Infectious Disease and

Tropical Medicine .12(38):63-6(2007).

• Ramezani A, Eslamifar A, Aghakhani A,…..Blood mercury levels in

infants receiving vaccines containing Thimerosal. Iranian Journal of

Infectious Disease and Tropical Medicine. 12(38):17-20(2007).

• Eslamifar A, Tirgari F, Hamkar R, Ramezani A …… Deljoodokht Z and

Aghakhani A. Role of the Human Papillomavirus infection in Esophageal

Squamous Cell Carcinoma. Iranian Journal of Pathology. 2(1):11-

16(2007).

• Naraghi M, Amidi Y, Eslamifar A. Demonstration of microbial biofilm in

Ethmoidal sinus of refractory chronic rhinosinusitis patients by SEM. The

Iranian journal of Otorhinolaryngology 18(46):181-4(2007).

• Ramezani A, Gachkar L, Eslamifar A…Prevalence of Hepatitis G virus

exposure in blood donors. Infectious diseases and tropical medicine

journal. 37(12).( 2007).

• Mahmoodi SMM, Hamkar R, …Eslamifar A…Determination of Human

Papillomavirus genotypes in cervical cancer speciemens in Yazd province.

Infectious diseases and tropical medicine journal. 37(12)( 2007).

• Ramezani A, Aghakhani A……Eslamifar A…. Natural YMDD mutants in

chronic B hepatitis. Iranian Journal of Infectious Diseases and Tropical

Medicine. 12(37): 1-6(2007).

18

• Eslamifar Ali, Aghakhani A, Hamkar R, Ramezani A,..... Frequency of

Human Papillomavirus Infection in Iranian Esophageal Squamous Cell

Carcinoma patients. Scandinavian Journal of Infectious Disease .39(1):58-

62(2007).

• Eslamifar A., Aghakhani A. Ramezani A.,... Detection of Hepatitis G

Virus Envelope Protein E2 Antibody in Dialysis Staff .Iranian Journal of

Infectious Diseases and Tropical Medicine. 11(35): 73-79 (2007).

• Eslamifar A., Aghakhani A. , Hamkar R., Ramezani A., Tirgari F., Frootan

H., Mirmomen Sh., Gheini MH. , Deljoodookht Z., Taeb J. Detection of

High Risk Human Papillomaviruses in Esophageal Squamous Cell

Carcinoma by PCR and DNA Sequencing. Iranian Journal of Infectious

Disease and Tropical Medicine. 11(33): 1-5(2006).

• Shahabi P, Mirnajafi J, Eslamifar A, Deljoo Z. Influence of electrical

destruction of Amygdal on convulsion due to..... Physiology and

Pharmacology Journal, Vol. 9, No. 2. (2005)

• Ramezani A, Mohraz M, Feizabadi M, Asgharzadeh A, Parastan R,

Eslamifar A, Aliahmadi A, Velayati A.A Molecular epidemiology of

clinical strains of enteococci Faecium in Tehran hospitals. Infectious

Diseases and Tropical Medicine Journal, Vol. 10, No. 31. .(2005)

• Ramezani A, Eslamifar A, Hazrati M. Study vaccine includes thiomersal

and relations with neurodevelopment disorders in neonates and embryonic

periods. Iranian Journal of Infectious Disease and Tropical Medicine, Vol.

9, No. 26. (2004)

19

• Ramezani A, Eslamifar A, Eslami N, Nazgooie F. Epidemiology of animal

rabies in Tehran province. Iranian Journal of Infectious Disease and

Tropical Medicine, Vol. 9, No. 25. (2004)

• Ramezani A, Eslamifar A, Nazgooie F, Falahian L, Hazrati M, Naseri

M.R. (2004) Study Epidemiology of animal bites in persons referred to

Institute Pasteur of Iran (Tehran province). Iranian Journal of Infectious

Disease and Tropical Medicine. Vol. 9, No. 27.( 2003)

• Ramezani A, Mohraz M, Asadi S, Nazgooie F, Eslamifar A. Survey

situation of nosocomial infection due to enterococci in Tehran hospitals.

Infectious Diseases and Tropical Medicine Journal, Vol. 7, No. 19. (2002)

Books:

• New edition of "Guide to antimicrobial therapy and vaccination" .Chief

Editor: Iranian Society for Infectious Diseases and Tropical Medicine

publication (2013)

• New edition of "Guide to antimicrobial therapy and vaccination". Pousheh

Publication, Tehran, Iran (2012)

• New edition of "Guide to antimicrobial therapy" .Chief Editor: Iranian

society for infectious diseases and tropical medicine publication

( 2005,2006,2007,2008,2009,2010)

• Application of Nanotechnology in medicine, Sharh Publication, Tehran

(2005).

• Health for Everybody. ISBN: 964-5888-81-6. Ahrar Publication in Tabriz

(2005)

20

Lectures/Seminars:

Lectures:

• Panel about vaccination. 8th

midyear conference of infectious diseases.

Babolsar, Iran (2009).

• Panel about Brucellosis treatment in 7th midyear conference of infectious

diseases. Isfahan, Iran (2008).

• Panel about Hepatitis in 6th midyear conference of infectious diseases.

Babolsar 16-19 Oct 2007.

• Panel about Hepatitis in 5th midyear conference of infectious diseases

Babolsar 1-2 Nov 2006.

• Panel about antimicrobial resistance in 5th midyear conference of

infectious diseases Babolsar 1-2 Nov 2006

• Lecture about nosocomial infection in midyear conference of infectious

diseases. Babolsar, 27-29 Sep. 2005

• Lecture about epidemiology of animal bites in Tehran province in seminar

of surveillance, treatment, prophylaxis for Rabies held in Pasteur Institute

of Iran, 2005

• Lecture about vaccination in midyear conference of infectious diseases.

Shiraz, 6 -7 Oct. 2004

• Panel about Exantematouse disease in 2nd Iranian Congress of Virology in

Imam Khomeini Hospital, 2004

• Lecture about apoptosis in liver cell due to drug toxin for general

physician in Mostafa Khomeini Hospital, 2004

21

Seminars

• Sofian M, Aghakhani A, Amir-Moezzi R , Zarinfar N, Banifazl M, Eslamifar

A and Ramezani A. Prevalence of HIV, HCV and HBV Infections and

Associated Risk Factors among Injecting Drug Users in Arak City. 21st Iranian

congress on infectious diseases and tropical medicine, Tehran, Iran (2013)

• Sofian M, Sheikholeslami M, Sarmadian H, Mahdaviani F, Aghakhani A,

Eslamifar A, Deiri GH, Ramezani A. Seroprevalence of Brucellosis

Antibodies in Blood Donors in Central Province of Iran. 21st Iranian congress

on infectious diseases and tropical medicine, Tehran, Iran (2013)

• Ramezani A, Mohraz M, Eslamifar A, Banifazl M, ….. and Aghakhani A.

Hepatitis E virus co-infection in HIV infected patients. 21st Iranian congress


• Aghakhani A, Aghasadeghi MR, Banifazl M, Eslamifar A, …..and Ramezani

A. Occult Hepatitis B Virus Infection in Hemodialysis Patients. 21st Iranian


• Sofian M, Safaeipour L, Aghakhani A, Banifazl M, Eslamifar A, Farazi A,

Didgar F, Ramezani A. Importance of Family Members Screening of Cases

with Acute Brucellosis. 21st Iranian congress on infectious diseases and

tropical medicine, Tehran, Iran (2013)

• Ramezani A, Eslamifar A, Banifazl M, Ahmadi F, Aghakhani A. Follow up of

Hemodialysis Patients with Occult Hepatitis B Virus Infection. 21st Iranian


• Ramezani A, Aghasadeghi M, Bahramali G, Aghakhani A, Banifazl M, …….

Eslamifar A, Siadat S, Mohraz M. Frequency of hepatitis D virus infection in

HIV-positive and haemodialysis patients in Iran. 22nd

European Congress of

22

Clinical Microbiology and Infectious Diseases (ECCMID), London, UK

(2012)

• Soufian S, Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, Mohraz M.

Reduction in interleukin-2 serum levels but lack of evidence of the Th1 to Th2

cytokine shift during the course of HIV infection. 22nd

European Congress of

Clinical Microbiology and Infectious Diseases (ECCMID), London, UK

(2012)

• Ramezani A, Sofian M, Aghakhani A, Farazi A, Banifazl M,. Eslamifar A,

Velayati A. Serum profile of T helper 1 and T helper 2 cytokines in HCV-

infected patients. 22nd

European Congress of Clinical Microbiology and

Infectious Diseases (ECCMID), London, UK (2012)

• Sofian M , Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, …..

Comparison of Brucella Induced epididymo-orchitis with Nonspecific

Epididymo-orchitis in an Endemic Area for Brucellosis. 20th

Iranian congress


• Ramezani A, Sofian M, Aghakhani A ,…. Banifazl M, Eslamifar A, …..

Serum Profile of T helper 1 and T helper 2 Cytokines in HCV Infected

Patients. 20th

Iranian congress on infectious diseases and tropical medicine,

Tehran, Iran (2011)

• Ramezani A, Aghasadeghi MR, Bahramali G, Aghakhani A, Banifazl M,

…..Eslamifar A, ….. Frequency of hepatitis D virus infection in HIV positive

and hemodialysis patients in Iran. 20th

Iranian congress on infectious diseases

and tropical medicine, Tehran, Iran (2011)

• Ramezani A, Aghakhani A, Banifazl M, Forough M, Eslamifar A and Mohraz

M. Seroprevalence of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and

23

HTLV-2 Infection in HIV Infected Patients. 20th

Iranian congress on

infectious diseases and tropical medicine, Tehran, Iran (2011)

• Ramezani A, Sofian M, Banifazl M, Aghakhani A,….. Eslamifar A, …..

Evaluation of Interleukin-10 Gene Promoter Polymorphisms and Hepatitis B

Virus Infection Outcome. 20th

Iranian congress on infectious diseases and

tropical medicine, Tehran, Iran (2011)

• Eslamifar A, Ramezani A, Mohraz M, Banifazl M, Forough M and Aghakhani

A. Tetanus and diphtheria seroprevalence in HIV infected patients. 20th

Iranian congress on infectious diseases and tropical medicine, Tehran, Iran

(2011)

• Ramezani A, ….., Aghakhani A, Soufian S, Eslamifar A and Banifazl M.

Mutations in the S gene region of hepatitis B virus in High Risk Patients with

Occult HBV Infection. 20th ECCMID, Vienna, Austria (2010)

• Eslamifar A, Aghakhani A, Banifazl M, Khadem-Sadegh A and Ramezani A.

Distribution of pertussis antibodies among Iranian children of different age

groups. 20th ECCMID, Vienna, Austria (2010)

• Aghakhani A, Hamkar R, Parvin M, Eslamifar A, Banifazl M and Ramezani

A. The Role of Human Papillomavirus Infection in Prostate Carcinoma. 14th

ICID - Miami, Florida, USA (2010)

• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Frequency of

isolated antibody to hepatitis B core antigen in HIV- HCV coinfected

individuals. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Association of

polymorphism of HLA-DRB1 13 and HLA-A 33 alleles with outcome of

hepatitis B virus infection. 14th ICID - Miami, Florida, USA (2010)

24

• Ramezani A, …,Aghakhani A, Eslamifar A, …. Banifazl M. No evidence of

occult hepatitis B virus infection among anti-HBc-positive blood donors in an

area of low endemicity for HBV. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Frequency of occult

hepatitis B virus infection in HIV infected patients. 14th ICID - Miami,

Florida, USA (2010)

• Ramezani A, …,Aghakhani A, Eslamifar A, …. Banifazl M. The

epidemiology of tuberculosis in Arak city, Central province of Iran from 1997-

2007. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Anti-HBs titers in

vaccinated children and adolescents: Implication for booster administration.

14th ICID - Miami, Florida, USA (2010)

• Ramezani A, Banifazl M,…….. Eslamifar A,… Aghakhani A. Prevalence of

Occult Hepatitis B Infection in Iranian Injection Drug Users. 14th ICID -

Miami, Florida, USA (2010)

• Eslamifar A, Ramezani A, Banifazl M, Bidari F, Moradi A and Aghakhani A.

Association of Human Papillomavirus and Breast Carcinoma.19th Iranian


• Ramezani A, Sofian M, Aghakhani A, Eslamifar A, Banifazl M. Occult and

chronic hepatitis B, hepatitis C, and HIV infections and co-infections among

injection drug users. 19th Iranian congress on infectious diseases and tropical

medicine, Tehran, Iran (2010)

• Ramezani A, Mohraz M, Aghakhani A, ….. Eslamifar A, …. Genotype

characterization of hepatitis G virus isolates from Iranian patients infected

with human immunodeficiency virus. 19th ECCMID, Helsinki, Finland(2009)

25

• Ramezani A, Aghakhani A, Mohraz M, Eslamifar A, Khadem-Sadegh A,

Banifazl M. Occult hepatitis B virus infection in “anti-HBc alone”

haemodialysis patients. 19th ECCMID, Helsinki, Finland(2009)

• Sofian M, Ramezani A, ….. Aghakhani A, Eshrati B, Eslamifar A, Banifazl

M. Predictive value of purified protein derivative in pulmonary tuberculosis in

a high BCG-vaccinated population. 19th ECCMID, Helsinki, Finland(2009)

• Aghakhani A, Hamkar R, …Eslamifar A,….Ramezani A. Identification of

hepatitis B virus genotype in patients with hepatocellular carcinoma in

Iran.19th ECCMID, Helsinki, Finland (2009)

• Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani

A.Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis

B Virus Infection. The 3rd Annual Iranian Congress on HIV/AIDS. Tehran,

Iran (2009)

• Aghakhani A, Mohraz M, Banifazl M, Eslamifar A, Khadem-Sadegh A and

Ramezani A. Frequency of isolated antibody to hepatitis B core antigen in

HIV- HCV coinfected individuals. The 3rd Annual Iranian Congress on

HIV/AIDS. Tehran, Iran (2009)

• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A,……Hamkar

R. Frequency of Occult Hepatitis B Virus Infection and its Surface Mutants in

HIV Positive Patients. The 3rd Annual Iranian Congress on HIV/AIDS.

Tehran, Iran (2009)

• Ramezani A, Sofian M, Aghakhani A, Eslamifar A, Izadi N, Banifazl M.

Occult hepatitis B virus infection in blood donors with isolated anti-HBc. 18th

Iranian congress on infectious diseases and tropical medicine, Tehran, Iran

(2009).

26

• Aghakhani A, Hamkar R, Parvin M, Eslamifar A, Banifazl M, Ramezani A.

Association of Human Papillomavirus with Prostate Cancer. 18th

Iranian

congress on infectious diseases and tropical medicine, Tehran, Iran (2009).

• Eslamifar A, Aghakhani A, Banifazl M, Khadem-Sadegh A, Ramezani A.

Seroepidemiology of pertussis antibodies among children of different age

groups. 18th


Tehran, Iran (2009).

• Ramezani A, Mohraz M, Hamkar R, Aghakhani A, Eslamifar A, Soufian S,

Banifazl M. Hepatitis B virus Surface Gene Mutations in High Risk Patients

with Occult HBV Infection. 18th

Iranian congress on infectious diseases and

tropical medicine, Tehran, Iran (2009).

• Ramezani A, Aghakhani A,…… Eslamifar A, Khadem-Sadegh A, Banifazl M.

Age specific seroprevalence of hepatitis A antibody: Implications for health

policy. 18th



• Ramezani A, Aghakhani A,…… Eslamifar A, Khadem-Sadegh A, Banifazl M.

Seroprevalence of hepatitis B surface antibody in children subjected to the

Expanded Programme on Immunization (EPI). 18th

Iranian congress on

infectious diseases and tropical medicine, Tehran, Iran (2009).

• Ramezani A, Mohraz M, Vahabpour R, …, Eslamifar A, Mahboudi F,

Aghakhani A, Edalat R, Hekmat S. Hepatitis G virus infection in patients

infected with the human immunodeficiency virus. 13th ICID - Kuala Lumpur,

Malaysia (2008)

27

• Ramezani A,…… Eslamifar A,…..Taeb J, Aghakhani A….. Association

between HLA-A, B, DRB1 alleles and susceptibility or resistance to chronic

hepatitis B. 13th ICID - Kuala Lumpur, Malaysia (2008)

• Ramezani A, Mohraz M,…. Aghakhani A, Eslamifar A…. Prevalence of

Metabolic abnormalities in HIV-Infected Patients Receiving Highly Active

Antiretroviral Therapy and antiretroviral-naive patients. 13th ICID - Kuala

Lumpur, Malaysia (2008)

• Ramezani A, Eslamifar A, Mohraz M,….. and Aghakhani A. Long term

Immune response to hepatitis B vaccine in hemodialysis patients. 13th ICID -

Kuala Lumpur, Malaysia (2008)

• Ramezani A,… Eslamifar A,……and Aghakhani A. Comparison of IFN-

gamma assay and Tuberculin Skin Test for detecting latent tuberculosis

infection in BCG-vaccinated population. 13th ICID - Kuala Lumpur, Malaysia

(2008)

• Eslamifar A, Aghakhani A ,Ramezani A,……. The role of fungi in the

etiology of chronic rhinosinusitis. 12th International Congress of Mycology.

Istanbul, Turkey(2008)

• Aghakhani A, Hamkar R,…….Eslamifar A,…..Ramezani A. Genotype

Characterization of Hepatitis B Virus Isolates from Iranian Patients with

Hepatocellular Carcinoma . 10th annual congress of pathology and 4th annual

congress of Iranian cancer association, Tehran, Iran (2008).

• Eslamifar A,…. Ramezani A,….and Aghakhani A. Frequency of Fungi and

Eosinophilic Granulocytes in Chronic Rhinosinusitis . 10th annual congress of

pathology and 4th annual congress of Iranian cancer association, Tehran, Iran

(2008).

28

• Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani A.

Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis B

Virus Infection. 17th Iranian congress on infectious diseases and tropical

medicine, Tehran, Iran (2008).

• Ramezani A, Mohraz M,….. Aghakhani A,… Eslamifar A and Velayati AA.

Genotype characterization of hepatitis G virus isolates from Iranian patients

infected with human immunodeficiency virus (HIV). 17th Iranian congress on


• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-

Sadegh A, Velayati AA. Frequency of isolated antibody to hepatitis B core

antigen in HIV- HCV coinfected individuals. 17th Iranian congress on


• Ramezani A, Aghakhani A,…. Eslamifar A,… Association of polymorphism

of HLA-DRB1*13 and HLA-A *33 alleles with outcome of hepatitis B virus

infection. 17th Iranian congress on infectious diseases and tropical medicine,


• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Velayati

AA. Frequency of occult hepatitis B virus infection in HIV infected patients.

17th Iranian congress on infectious diseases and tropical medicine, Tehran,

Iran (2008).

• Ramezani A, Aghakhani A, Eslamifar A, Khadem-Sadegh A, Banifazl M.

Occult hepatitis B virus infection in "anti-HBc alone" hemodialysis patients.

17th Iranian congress on infectious diseases and tropical medicine, Tehran,

Iran (2008).

29

• Panel about Diagnosis and treatment of chronic Brucellosis and Brucellosis

relapse. 7th midyear conference of infectious diseases. Isfahan, Iran (2008).

• M. Soofian, A. Ramezani, ......, A. Aghakhani, A. Eslamifar. Risk factors for

human brucellosis in Iran: a case control study. ECCMID-ICC, Munich,

Germany(2007).

• Eslamifar A. ,Aghakhani A. ,Ramezani A,…… Prevalence of hepatitis G

exposure in patients on chronic dialysis. 21st European Congress of

Pathology, Istanbul, Turkey (2007).

• A. Kariminia, Z. sharifnia, A. Aghakhani, M. Banifazl , A. Eslamifar,

M.Hazrati and A. Ramezani. Performance of QuantiFERON TB-G Test for

detecting latent tuberculosis infection in BCG-vaccinated population. 16th

Iranian congress on infectious diseases and tropical medicine, Tehran,Iran

(2007).

• A.Ramezani, A.Eslamifar......and A.Aghakhani. Persistence of Hepatitis B

Vaccine Immunity in Hemodialysis Patients.16th Iranian congress on

infectious diseases and tropical medicine, Tehran,Iran (2007).

• A.Ramezani,M.Mohraz,....A.Aghakhani,A.Eslamifar,... Frequency of hepatitis

B and hepatitis C virus infections in HIV infected subjects.16th Iranian

congress on infectious diseases and tropical medicine, Tehran,Iran (2007).

• A.Ramezani,M.Mohraz,....A.Aghakhani,A.Eslamifar,... Impact of

antiretroviral treatment on lipid profile in HIV infected patients. 16th Iranian


30

• A.Ramezani,M.Mohraz,....A.Aghakhani,A.Eslamifar,... Anemia in HIV-

infected patients receiving highly active antiretroviral therapy. 16th Iranian


• A.Ramezani.MR Hasanjani Roshan,...A.Eslamifar.....J, Taeb, A. Aghakhani....

Influence of HLA class І and II alleles on the outcome of hepatitis B virus

infection. 16th Iranian congress on infectious diseases and tropical medicine,

Tehran,Iran (2007).

• A.Ramezani....... A.Eslamifar and A. Aghakhani. Detection of YMDD

mutation in Iranian chronic hepatitis B patients before lamivudine treatment.

9th annual congress of pathology and 3rd annual congress of Iranian cancer

association, Tehran, Iran (2007).

• Esalamifar A, Aghakhani A, Hamkar R, Ramezani A....Frequency of Human

Papillomavirus Infection in Esophageal Squamous Cell Carcinoma of Iranian

patients. 12th International Congress on Infectious Diseases, Lisbon,

Portugal (2006)

• Eslamifar A, Ramezani A....and Aghakhani A. Hepatitis G virus exposure in

dialysis patients. 8th annual congress of pathology and 2nd congress of

oncology, Tehran, Iran (2006)

• Eslamifar A , Hamkar R, Ramezani A....and Aghakhani A. Role of human

papillomavirus infection in esophageal carcinoma.8th annual congress of

pathology and 2nd congress of oncology, Tehran, Iran (2006)

• Eslamifar A, Aghakhani A, Ramezani A, et al. Epidemiology of Animal Bites

in Tehran.15th Iranian congress on infectious diseases and tropical medicine,

Tehran,Iran (2006)

31

• Eslamifar A, Hamkar R, Ramezani ……and Aghakhani A. Hepatitis G virus

(HGV) Exposure in Dialysis Staff. 15th Iranian congress on infectious

diseases and tropical medicine, Tehran,Iran (2006)

• Ramezani A , ………, Eslamifar A and Aghakhani A .YMDD mutants in

patients with chronic hepatitis B before treatment are not selected by

lamivudine.15th Iranian congress on infectious diseases and tropical medicine,

Tehran,Iran (2006)

• Eslamifar A, Hamkar R, Ramezani ……and Aghakhani A. Exposure to

Hepatitis GB Virus in Patients on Maintenance Hemodialysis. 15th Iranian

congress on infectious diseases and tropical medicine, Tehran,Iran (2006)

• Ramezani A, Eslamifar A….Factors influencuing to hepatitis B virus

vaccination in hemodialysis patiens. XLIII ERA-EDTA Congres(Glasgow,

United Kingdom, July 15-18,( 2006)

• Ramezani A, Eslamifar A….Frequency of Hepatitis G infection among Iranian

blood donors.12th international congress on infectious diseases, Lisbon

,Portugal(2006)

• Ramezani A ,Eslamifar A…Assesment of blood mercury levels in infants

exposed to vaccines containing thiomersal. 2nd international congress on

infectious and tropical diseases in Oman( 2006)

• Ramezani A, Eslamifar A…Efficacy of hepatitis B vaccination schedule and

comparing to complete regimen hemodialysis patients of Iran.12th

international congress on infectious diseases, Lisbon ,Portugal(2006)

• Gachkar L, Ramezani A, Eslamifar A, Hamkar R, Khoshbaten M, Hazrati M.

Frequency of hepatitis G infection among Iranian blood donors. 14th Congress

of Infectious Disease on 17-21 Dec. (2005)

32

• Ramezani A, Mohraz M, Feiabadi M, Banifazl M, Eslamifar A, Velayati A.A.

Frequency of vancomycin resistant Enterococci faecium in hospitals of

Tehran. 14th Congress of Infectious Disease on 17-21 Dec. (2005)

• Ramezani A, Eslamifar A, Hazrati Mb, Mohraz M. Factors influencing to

hepatitis B vaccination response in hemodialysis patients of Tehran (Iran).

14th Congress of Infectious Disease on 17-21 Dec. (2005)

• Eslamifar A .Case report of skull plasmocytic granulom and study Efficacy of

electron microscopy on diagnosis. Congress of Pathology. (2004)

• Ramezani A, Eslamifar A, Heidari L, Hosseini H, Hazrati M. Rates of scar

failure in children vaccinated with BCG. 13th Congress of Infectious

Diseases.11-15 December. (2004)

• Eslamifar A, Ramezani A, Nazgooie F,Mafakheri M, Hosseini Z Naseri M.R.

Situation of MR vaccination on mass campaign project in persons referred to

Pasteur Institute of Iran. 12th Congress of Infectious Diseases. (2003)

Theses (Supervisor):

• Comparison of GMS and Chitinase staining in fungal chronic

rhinosinusitis(Ali Khameneh for MS in Microbiology)

Theses (Advisor):

• Demonstration of Bacterial Biofilms in Cavities of Symptomatic post-

Endoscopic Sinus Surgery with Scanning Electron Microscope(Dr.Yasha

Amidi for ENT specialty)

33

• Efficacy of poly methyl metacrylate and antiblastic drugs(MTX,

Doxorubicine and cysplatin) in Giant cell tumor (Parham Sadeghipoor for

MD)

• Effects of Akacid on growth and morphology of aflatoxin producing

Aspergillus parasiticus (Mohammad Sheikhi for DVM)

cv dr eslam final - pasteurfa.pasteur.ac.ir/userfiles/file/amozesh/cv asatid 92/cv dr...curriculum...

Documents